In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?

被引：286
|
作者：
Zhang, Yuan [1 ]
Satterlee, Andrew [1 ]
Huang, Leaf [1 ]
机构：
[1] Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
来源：
MOLECULAR THERAPY | 2012年 / 20卷 / 07期
关键词：
NANO DEVICE MEND; TARGETED DELIVERY; SYSTEMIC DELIVERY; CATIONIC LIPIDS; SIRNA DELIVERY; MESSENGER-RNA; NUCLEIC-ACID; OFF-TARGET; NANOPARTICLES; PEG;
D O I：
10.1038/mt.2012.79
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The promise of cancer gene therapeutics is hampered by difficulties in the in vivo delivery to the targeted tumor cells, and systemic delivery remains to be the biggest challenge to be overcome. Here, we concentrate on systemic in vivo gene delivery for cancer therapy using nonviral vectors. In this review, we summarize the existing delivery barriers together with the requirements and strategies to overcome these problems. We will also introduce the current progress in the design of nonviral vectors, and briefly discuss their safety issues. Received 26 January 2012; accepted 29 March 2012; advance online publication 24 April 2012. doi:10.1038/mt.2012.79
引用
收藏
页码：1298 / 1304
页数：7
相关论文
共 50 条
  • [21] Nonviral vectors in the new millennium: Delivery barriers in gene transfer
    Nishikawa, M
    Huang, L
    HUMAN GENE THERAPY, 2001, 12 (08) : 861 - 870
  • [22] Gemini Amphiphiles: A Novel Class of Nonviral Gene Delivery Vectors
    Kumar, Mukesh
    Jinturkar, Kaustubh
    Yadav, M. R.
    Misra, Ambikanandan
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2010, 27 (03): : 237 - 278
  • [23] Hyperbranched polysiloxysilane nanoparticles for nonviral gene delivery vectors and nanoprobes
    Kim, Won Jin
    Bonoiu, Adela C.
    Lee, Kwang-Sup
    Hayakawa, Teruaki
    Xia, Cheng
    Kakimoto, Masa-aki
    Pudavar, Haridas E.
    Prasad, Paras N.
    NANOBIOSYSTEMS: PROCESSING, CHARACTERIZATION, AND APPLICATIONS II, 2009, 7403
  • [24] Polycationic Nanoparticles as Nonviral Vectors Employed for Gene Therapy in vivo
    Xing, Jinfeng
    Deng, Liandong
    Guo, Shutao
    Dong, Anjie
    Liang, Xing-Jie
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (02) : 126 - 137
  • [25] In vivo gene delivery by lentiviral vectors
    Naldini, L
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 552 - 554
  • [26] Synergism in gene delivery by small PEIs and three different nonviral vectors
    Lampela, P
    Soininen, P
    Urtti, A
    Männistö, PT
    Raasmaja, A
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 270 (1-2) : 175 - 184
  • [27] Sleeping Beauty transposase-transposon cis-vectors for efficient nonviral gene delivery and persistent gene expression in vivo
    Mikkelsen, JG
    Yant, SR
    Meuse, L
    Huang, Z
    Xu, H
    Kay, MA
    MOLECULAR THERAPY, 2003, 7 (05) : S74 - S74
  • [28] Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery
    Finsinger, D
    Remy, JS
    Erbacher, P
    Koch, C
    Plank, C
    GENE THERAPY, 2000, 7 (14) : 1183 - 1192
  • [29] Cationic copolymers nanoparticles for nonviral gene vectors: Synthesis, characterization, and application in gene delivery
    d'Ayala, Giovanna Gomez
    Calarco, Anna
    Malinconico, Mario
    Laurienzo, Paola
    Petillo, Orsolina
    Torpedine, Angela
    Peluso, Gianfranco
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 94A (02) : 619 - 630
  • [30] Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery
    D Finsinger
    J-S Remy
    P Erbacher
    C Koch
    C Plank
    Gene Therapy, 2000, 7 : 1183 - 1192
12345